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A B S T R A C T
Multiple Myeloma (MM) is a relatively rare disease and MM presenting outside the bone marrow, known as
extramedullary myeloma (EMM), is rarer still. While the liver and CNS are most commonly affected in EMM, the
lung parenchyma is an especially unusual site of involvement.
We present the case of a 64-year-old male with known history of MM admitted with acute respiratory failure
and a chest wall mass. Chest CT revealed patchy interstitial and alveolar opacities with no pulmonary masses or
nodules. Bronchoalveolar lavage (BAL) was performed, with flow cytometry demonstrating monoclonal plasma
cells expressing CD38, CD138 and CD56 with lambda light chain restriction. Fine Needle Aspiration of chest wall
mass revealed CD138-positive cells as well.
Review of the literature revealed only one other documented case of a patient presenting with both interstitial
lung parenchymal involvement with MM as well as soft tissue plasmacytoma, with this occurring in a patient
who had previously underwent stem cell transplant. To our knowledge, we report the first recorded case of this
presentation in a patient without a history of stem cell transplantation. Furthermore, it demonstrates the utility
of using BAL, rather than lung biopsy, to establish the diagnosis through less invasive means.
1. Introduction
Multiple Myeloma (MM) is a relatively rare disease, with an esti-
mated incidence in the Western World of 5 cases per 100,000 [1]. Rarer
still is myeloma that arises from sights distinct from the bone marrow,
such as soft tissue plasmacytomas or plasma cell infiltration of other
anatomical structures. This manifestation, known as extramedullary
myeloma (EMM), is present in 6%–8% of patients at the time of mye-
loma diagnosis, and the incidence increases over the duration of the
disease with 10%–30% of myeloma patients eventually presenting with
EMM [2]. Common sites of EMM involvement include hepatic, renal,
pancreatic, pleural and the CNS. However, the pulmonary parenchyma
is rarely involved [2,3]. One large study of 958 patients with MM found
only 4 patients with presentations suggesting pulmonary infiltration by
myeloma cells. Only one of these cases was proven histologically [3].
We present a case of a patient presenting with diffuse interstitial lung
disease (ILD) found to be consistent with myelomatous involvement as
well as a soft tissue plasmacytoma.
2. Case
A 64-year-old male with a history of hypertension and multiple
myeloma status post chemotherapy five months prior presented to the
ER in acute hypoxic respiratory failure. On exam, he was afebrile, his
heart rate was 128 bpm, and he was hypoxic with SpO2 of 70% on a
non-rebreather. Chest auscultation revealed diffuse, bilateral crackles.
The patient was promptly admitted to ICU and intubated.
One day prior to the current admission, the patient had been dis-
charged from the hospital after treatment for relapsed MM. His course
during this time was complicated by acute hypoxic respiratory failure
necessitating intubation and ICU admission which was presumed sec-
ondary to pneumonia. During this previous admission the patient was
also found to have a right chest wall mass and Fine Needle Aspiration
revealed monoclonal plasma cells that were CD138-positive.
During his current admission a high-resolution Chest CT was ob-
tained and demonstrated patchy interstitial and alveolar opacities with
no pulmonary masses or nodules (see Figs. 1 and 2). Bronchoscopy
revealed 27% lymphocytes and was negative for evidence of infection.
Bronchoalveolar lavage (BAL) flow cytometry demonstrated mono-
clonal plasma cells expressing CD38, CD138 and CD56 with lambda
light chain restriction (see Fig. 3). The patient's condition worsened,
and he expired due to complications of MM. Autopsy was declined.
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3. Discussion
While pulmonary findings in MM are relatively common, the over-
whelming majority of these are related to an infectious etiology [3].
Review of the literature revealed seven case reports of patients with
MM found to have interstitial pulmonary infiltration with neoplastic
plasma cells, of which two were the initial presentation of myeloma and
five were in patients previously diagnosed and treated [4–10]. The
clinical picture can also differ significantly, from a more insidious onset
of cough and shortness of breath to a rapidly progressive presentation
resembling the Acute Respiratory Distress Syndrome (ARDS) [6,8–10].
Our patient presented both with pulmonary parenchymal involve-
ment by MM and a subcutaneous plasmacytoma. Search of the litera-
ture revealed one similar case of a patient presenting with both pul-
monary and skin involvement [4]. However, this previously reported
case occurred after autologous stem cell transplant for previously di-
agnosed MM.
Our patient's BAL results revealed monoclonal plasma cells on flow
cytometry. This approach to diagnosis is significant given that a diag-
nosis of MM causing ILD can be challenging to confirm. In the majority
of cases reviewed, the diagnosis was either made via biopsy (trans-
bronchial or surgical) or at autopsy [6–10]. However, two cases were
reported in the literature of BAL flow cytometry revealing monoclonal
plasma cells in patients who had histologically proven myelomatous
involvement of the pulmonary parenchyma [4,5]. These two cases,
along with the case we have presented, suggest that evaluation of BAL
samples by flow cytometry could help establish the diagnosis and avoid
the need for more invasive biopsy techniques.
4. Conclusion
In conclusion, we present a case of a patient with pulmonary
parenchymal infiltration by MM as well as subcutaneous plasma-
cytoma. To our knowledge this is the first such presentation in a
patient without a history of stem cell transplant. MM should be
considered on the differential diagnosis of patients with the ap-
propriate clinical history and interstitial infiltrates. Furthermore,
flow cytometry of BAL samples should be considered in patients
with known or suspected MM and a pattern on imaging consistent
with ILD.
Abbreviations
ARDS Acute Respiratory Distress Syndrome
BAL Bronchoalveolar lavage
EMM Extra Medullary Myeloma
ILD Interstitial Lung Disease
MM Multiple Myeloma
Fig. 1. Chest CT revealing showing large right sided chest wall mass.
Fig. 2. Chest CT showing bilateral patchy alveolar and interstitial opacities,
affecting primarily the upper lobes.
Fig. 3. Flow cytometry figure demonstrating CD138+, CD38 + and CD56+ plasma cells with lambda light chain restriction.
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